Akero Therapeutics Aktie
WKN DE: A2PLNP / ISIN: US00973Y1082
28.02.2025 14:12:38
|
Akero Therapeutics Inc. Q4 Loss Beats Estimates
(RTTNews) - Akero Therapeutics Inc. (AKRO) released Loss for fourth quarter that beat the Street estimates.
The company's earnings totaled -$70.03 million, or -$0.99 per share. This compares with -$55.2 million, or -$0.99 per share, last year.
Analysts on average had expected the company to earn -$1.12 per share. Analysts' estimates typically exclude special items.
Akero Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$70.03 Mln. vs. -$55.2 Mln. last year. -EPS: -$0.99 vs. -$0.99 last year.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Akero Therapeutics Inc Registered Shs Accred Invmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Akero Therapeutics Inc Registered Shs Accred Invmehr Analysen
Aktien in diesem Artikel
Akero Therapeutics Inc Registered Shs Accred Inv | 33,05 | -1,43% |
|